Übersichtsartikel und Buchkapitel


Pietzsch,H-J., Liolios,C.: Clinically relevant (exclusive) diagnostic SPECT tracers: radiolabeling precursor & complexing agent approaches; outlook on future SPECT tracers of clinical relevance. In: Clinical Nuclear Medicine, Radiopharmaceutical Sciences. Biersack, H.-J., Freeman, L.M., Springer, 2017.


Eder, M., Eisenhut, M., Babich, J., Haberkorn, U.: PSMA as a target for radiolabelled small molecules. Eur J Nucl Med Mol Imaging 40(6), 819-823, 2013.

Waerzeggers, Y., Viel, T., Schäfers, S., Wagner, S., Faust, A., Riemann, B., Kopka, K., Schober, O., Schäfers, K., Jacobs, A.H.: Positron Emission Tomography (PET)-based Molecular Imaging. Chapter in „animal models of brain tumors“, Part 5 - Imaging Technologies in Animal Tumor Models: Measuring Brain Tumor Growth and Metabolism (series of Neuromethods) 77, 301-327, 2013.

Wagner, S., Kopka, K.: Non-peptidyl 18F-labelled PET tracers as radioindicators for the noninvasive detection of cancer. Recent Results Cancer Res 187, 107-132, 2013.


Sarko, D., Eisenhut, M., Haberkorn, U., Mier, W.: Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases. Curr Med Chem 19(17), 2667-2688, 2012.


Haberkorn, U., Markert, A., Eisenhut, M., Mier, W., Altmann, A.: Development of molecular techniques for imaging and treatment of tumors. Q J Nucl Med Mol Imaging 55(6), 655-670, 2011.

Waerzeggers, Y., Monfared, P., Viel, T., Faust, A., Kopka, K., Schäfers, M., Tavitian, B., Winkeler, A., Jacobs, A.H.: Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments. Br J Radiol 84(Special Issue 2), S168-S178, 2011.


Kopka, K., Wagner, S.: Radiopharmaceuticals for PET. In PET-CT Hybrid Imaging; Schober O, Heindel W, eds.; Georg Thieme Verlag KG: Stuttgart, pp. 14-25, 2010.


Faust, A., Hermann, S., Wagner, S., Haufe, G., Schober, O., Schäfers, M., Kopka, K.: Molecular Imaging of Apoptosis In vivo with Scintigraphic and Optical Biomarkers - A Status Report. Anticancer Agents Med Chem 9(9), 968-985, 2009.

Haberkorn, U., Eisenhut, M., Altmann, A., Mier, W.: Molecular endoradiotherapy of cancer. Minerva Biotecnol 21, 5-19, 2009.

Höltke, C., Faust, A., Breyholz, H.J., Kopka, K., Schober, O., Riemann, B., Bremer, C., Schäfers, M., Wagner, S.: Non-invasive Approaches to visualize the Endothelin Axis in vivo using state-of-the-art Molecular Imaging Modalities. Mini Rev Med Chem 9(14), 1580-1595, 2009.

Oltmanns, D., Eisenhut, M., Mier, W., Haberkorn, U.: Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors. Curr Med Chem 16(17), 2086-2094, 2009.

Zoller, F., Eisenhut, M., Haberkorn, U., Mier, W.: Endoradiotherapy in cancer treatment - Basic concepts and future trends. Eur J Pharmacol 625(1-3), 55-62, 2009.

nach oben